Intrauterine growth retardation and long-term effects on growth

Current Opinion in Pediatrics

Volumn 11, Issue 4, 1999, Pages 340-347

  Botero, Diego ^a   Lifshitz, Fima ^a  

^a MIAMI CHILDREN'S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; HUMAN GROWTH HORMONE; SOMATOMEDIN B; SOMATOMEDIN C;

CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; FAILURE TO THRIVE; FETUS GROWTH; FETUS WEIGHT; GROWTH INHIBITION; HUMAN; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; REVIEW; SHORT STATURE;

ADULT; CHILD; FAILURE TO THRIVE; FETAL GROWTH RETARDATION; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; INFANT, NEWBORN; MORBIDITY; PREVALENCE; PROGNOSIS; RISK FACTORS;

EID: 0032866897     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-199908000-00013     Document Type: Review

References (66)

1. Hediger ML, Overpeck MD, Maurer KR, Kuczmarski RJ, McGlynn A, Davis WW: Growth of infants and young children born small for large for gestational age: findings from the third national health and nutrition examination survey. Arch Pediatr Adolesc Med 1998, 152:1225-1231.
2. McCormick M: The contribution of low birth weight to infant mortality and childhood morbidity. N Engl J Med 1985, 312:82-90.
3. McIntire DD, Bloom SL, Casey BM, Leveno KJ: Birth weight in relation to morbidity and mortality among newborn infants. N Engl J Med 1999, 340:1234-1238.
4. Fjellestad-Paulsen A, Czernichow P, Brauner R, Bost M, Colle M, Lebouc JY, et al.: Three year data from a comparative study with recombinant human growth hormone in the treatment of short stature in young children with intrauterine growth retardation. Acta Paediatr 1998, 87:511-517.
5. Chaussain JL, Colle M, Landier F: Effects of growth hormone therapy in prepuberal children with short stature secondary to intrauterine growth retardation. Acta Paediatr 1994, 399(suppl):75.
6. Coutant R, Carel JC, Letrait M, Bouvattier C, Chatelain P, Coste J, Chaussain JL: Short stature associated with intrauterine growth retardation: final height of untreated and growth hormone-treated children. J Clin Endocrinol Metab 1998, 83:1070-1074.
7. Barker DJP, Gluckman PD, Godfrey KM, Harding JE, Owens JA, Robinson JS: Fetal nutrition and cardiovascular disease in adult life. Lancet 1993, 341:938-941.
8. Williams S, St George IM, Silva PA: Intrauterine growth retardation and blood pressure at age seven and eighteen. J Clin Epidemiology 1992, 45:1257-1263.
9. Leger J, Levy-Marchal C, Bloch J, Pinet A, Chevene D, Porquet D, et al.: Reduced final height and indications for insulin resistance in 20 year olds born small for gestational age: regional cohort study. BMJ 1997, 315:341-347.
10. Laor A, Stevenson DK, Shemer JG, Rena S, Daniel S: Size at birth, maternal nutritional status in pregnancy, and blood pressure at age 17. BMJ 1997, 315:449-453.
11. Rich-Edwards JW, Colditz, GA, Stampfer MJ, Willet WC, Gillman MW, Hennekens CH: Birthweight and the risk for type 2 diabetes mellitus in adult women. Ann Inter Med 1999, 130:278-284.
12. Lithell HO, McKeigue PM, Berglund L, Mohsen R, Lithell UB, Leon DA: Relation of size at birth to non-insulin dependent diabetes and insulin concentrations in men aged 50-60 years. BMJ 1996, 312:406-410.
13. Hofman PL, Cutfield WS, Robinson EM, Bergman RN, Menon RK, Sperling MA, et al.: Insulin resistance in short children with intrauterine growth retardation. J Clin Endocrinol Metab 1997, 82:402-406.
14. Barker DJP, Gluckman PD, Robinson JS: Fetal origins of adult disease: report of the first study group, Sydney, 29-30 October, 1994. Placenta 1995, 16:317-320.
15. Lubchenko LO, Hansman C, Dressler, Body E: Intrauterine growth as estimated from live born birth weight data at 24-42 weeks of gestation. Pediatrics 1963, 32:793-800.
16. Usher R, McLean F: Intrauterine growth of live born Caucasian infants at sea level: standards obtained from measurements in 7 dimensions of infants born between 25 and 44 weeks of gestation. Pediatrics 1969, 74:901-910.
17. Goldberg RL, Cutter GR, Hoffman HJ, Foster JM, Nelson KG, Hauth JC, et al.: Intrauterine growth retardation: standards for diagnosis. Am J Obstet Gynecol 1989, 161:271-277.
18. Seeds JW, Peng T: Impaired growth and risk of fetal death: is the tenth percentile the appropriate standard? Am J Obstet Gynecol 1998, 178:658-667.
19. Gabbe SG: Intrauterine growth retardation. In Obstetrics: Normal and Problem Pregnancies, edn 2. Edited by Gabbe SG, Niebyl JR, Simpson JL. New York: Churchill Livingstone; 1991:993-994.
20. Creasy RK, Resnick R: Intrauterine growth retardation. In Maternal Fetal Medicine: Principles and Practice, edn 3. Edited by Creasy RK, Resnick RK. Philadelphia: WB Saunders; 1994:558-574.
21. Brenner WE, Edelman DA, Hendricks CH: A standard for fetal growth for the United States of America. Am J Obstet Gynecol 1976, 126:555-564.
22. Singer DB, Sung CJ, Wigglesworth JS: Fetal growth and maturation: with standards for body and organ development. In Textbook of Fetal and Perinatal Pathology. Edited by Wigglesworth JS, Singer DB. Boston: Blackweel Scientific Publications; 1996:11-47.
23. Klebanoff MA, Meirik O, Berendes HW: Second generation consequences of small-for-dates birth. Pediatrics 1989, 84:343-347.
24. Tudehope DI: Neonatal aspects of intrauterine growth retardation. Fetal Med Rev 1991, 3:73-85.
25. Berge P, Stagno S, Federer W, Cloud G, Foster J, Utermohlen V, et al.: Impact of asymptomatic congenital cytomegalovirus infection on size at birth and gestational duration 1990. Pediatr Infect Dis 1990, 9:170-175.
26. Khoury MJ, Erickson JD, Cordero JF, McCarthy BJ: Congenital malformations and intrauterine growth retardation: a population study. Pediatrics 1988, 82:83-90.
27. Kohler M, Moya-Sola S, Agusti J: Imprinted gene in postnatal growth role. Nature 1998, 393:125-126.
28. Godfrey K, Robinson S, Barker DJP, Osmond C, Cox V: Maternal nutrition in early and late pregnancy in relation to placental and fetal growth. BMJ 1996, 312:410-414.
29. Luke B, Gillespie B, Min S-J, Avni M, Witter FR, O'Sullivan MJ: Critical periods of maternal weight gain: effect on twin birth weight. Am J Obstet Gynecol 1997, 177:1055-1062.
30. Abrams B, Selvin S: Maternal weight gain pattern and birth weight. Obstet Gynecol 1995, 86:163-169.
31. Food and Nutrition Board, Institute of Medicine (United States): Nutrition During Pregnancy: Report of the Committee on Nutritional Status During Pregnancy and Lactation. Washington: National Academy Press; 1990:1-233.
32. Johnson, JWC, Yancey MK: A critique of the new recommendations for weight gain in pregnancy. Am J Obstet Gynecol 1996, 174:254-258.
33. American College of Obstetricians and Gynecologists: Nutrition During Pregnancy. Washington: American College of Obstetricians and Gynecologists; 1993. [Technical bulletin no. 179.]
34. Brown HL, Watkings K, Hiett KA: Fetus-placenta-newborn: the impact of the women, infants and children food supplement program on birth outcome. Am J Obstet Gynecol 1996, 174:279-283.
35. Cogswell, ME, Serdula MK, Hungerford DW, Yip R: Gestational weight gain among average-weight and overweight women-what is excessive? Am J Obstet Gynecol 1995, 172:705-712.
36. Krook A, Brueton L, O'Rahilly S: Homozygous nonsense mutation in the insulin receptor gene in infant with leprechaunism. Lancet 1993, 342:227-228.
37. Furlanetto RW, Underwood LE, Van Wyk JJ, Handweger S: Serum immunoreacive somatomedine-C is elevated in late pregnancy. J Clin Endocrinol Metab 1979, 47:695-698.
38. Freemark M, Comer M, Mularoni T, D'Ercole AJ, Granois A, Kodack L: Nutritional regulation of the placental lactogen receptor in fetal liver: implications for fetal metabolism and growth. Endocrinology 1989, 125:1504-1512.
39. Leger J, Noel M, Limal JM, Czernichow P, for the Study group of IUGR: Growth factors and intrauterine growth retardation: II: serum growth hormone, insulin-like growth factor (IGF)-1 and IGF binding protein 3 levels in children with untrauterine growth retardation compared with normal control subjects: prospective study from birth to two years of age. Pediatr Res 1996, 40:101-107.
40. Cance-Rouzaud A, Laborie S, Bieth E, Tricoire J, Rolland M, Grandjean H, et al.: Growth hormone, insulin like growth factor-1 and insulin like growth factor binding protein-3 are regulated differently in small-for-gestational-age and appropriate-for-gestational-age neonates. Biol Neonate 1998, 73:347-355.
41. Lassarre C, Hardouing S, Daffos F, Forestier F, Frankenne F, Binoux M: Serum insulin-like growth factors and insulin-like growth factor binding proteins in normal subjects and in subjects with intrauterine growth retardation. Pediatr Res 1991, 29:219-225.
42. Job JC, Chatelain P, Rochiccioli P, Ponte C, Oliver M, Sagard L: Growth hormone response to a bolus injection of 1-44 growth-hormone-releasing hormone in very short children with intrauterine onset growth failure. Horm Res 1990, 33:161-165.
43. Weber GW, Prossinger H, Horst S: Height depends on month of birth. Nature 1998, 39:754-755.
44. Jaquet D, Leger J, Levy-Marchal C, Oury JF, Czernichow P: Ontogeny of leptin in human fetuses and newborns effect of intrauterine growth retardation on serum leptin concentrations. J Clin Endocrinol Metab 1998, 83:243-246.
45. Marchini G, Fried G, Ostlund E, Gagenas L: Plasma leptin in infants: relations to birth weight and weight loss. Pediatrics 1998, 101:429-432.
46. Chang TC, Robson SC, Boys RJ, Spencer JAD: Prediction of the small for gestational age infant: which ultrasonic measurement is best? Obstet Gynecol 1992, 80:1030-1038.
47. Bahado-Singh R, Oz U, Kovanchi E, Lermik E, Flores D, Singh-Basra D, et al.: Mid-trimester maternal urine marker for the prediction of subsequent IUGR. Am J Obstet Gynecol 1999, 180(suppl II):174-175.
48. Georgieff MK, Sasanow SR, Chockalingam UM, Pereira GR: A comparison of the mid-arm circumference/head circumference ratio and the ponderal index for the evaluation of newborn infants after abnormal intrauterine growth. Acta Paediatr Scand 1988, 77:214-219.
49. Karlberg J, Albertsson-Wikland K: Growth in full-term small-for-gestational-age infants: from birth to final height. Pediatr Res 1995, 38:733-739.
50. Leger J, Limoni C, Collin D, Czernichow P: Prediction factors in the determination of final height in subjects born small for gestational age. Pediatr Res 1998, 43:808-812.
51. Achermann JC, Hamdani K, Hindmarsh PC, Braok CG: Birth weight influences the initial response to growth hormone treatment in growth-hormone-insufficient children. Pediatrics 1998, 102:342-345.
52. Strauss RS, Dietz WH: Growth and development of term children born with low birth weight: effects of genetic and environmental factors. J Pediatr 1998, 133:67-72.
53. Woods KA, Camacho-Hubner C, Savage MO, Clark AJL: Intrauterine growth retardation and postnatal growth failure associated with deletion of the insulin-like growth factor I gene. N Engl J Med 1996, 335:1363-1367.
54. Kelleher KJ, Casey PH, Bradley RH, Pope SK, Whiteside L, Barret KW, et al.: Risk factors and outcomes for failure to thrive in low birth weight preterm infants. Pediatrics 1993, 91:941-948.
55. Lifshitz F, Cervantes CD: Short stature. In Pediatric Endocrinology: A Clinical Guide. Edited by Lifshitz F. New York: Marcel Dekker; 1996:1-32.
56. Boguszewski M, Albertsson-Wikland K, Aronsson S, Gustafsson J, Hagenas L, Westgren U, et al.: Growth hormone treatment of short children born small-for-gestational-age: the Nordic Multicentre Trial. Acta Paediatr 1998, 87:257-263.
57. Chernausek SD, Breen TJ, Frank GR: Linear growth in response to growth hormone treatment in children with short stature associated with intrauterine growth retardation: The National Cooperative Growth Study experience. J Pediatr 1996, 128(suppl):22-27.
58. Zegher F, Albertsson-Wikland K, Wilton P, et al.: Growth hormone treatment of short children born small for gestational age: metanalysis of four independent, randomized, controlled, multicentre studies. Acta Paediatr 1996, 417(suppl):27-31.
59. Job JC, Chaussain JL, Job B, Ducret JP, Maes M, Oliver M, et al.: Follow-up of three years of treatment with growth hormone and one of post-treatment year, in children with severe growth retardation of intrauterine onset. Pediatr Res 1996, 39:354-359.
60. Botero D, Danon M, Brown RS: Symptomatic non-insulin dependent diabetes mellitus during therapy with recombinant human growth hormone. J Pediatr 1993, 123:590-592.
61. Persson E, Jansson T: Low birthweight is associated with elevated adult blood pressure in the chronically catheterized guinea pig. Acta Physiol Scand 1992, 145:195-196.
62. Dahri S, Snoeck A, Reusens-Billen B, Hoet JJ: Effect of a low protein diet during pregnancy on the fetal rat endocrine pancreas. Biol Neonate 1991, 40(suppl 2):115-120.
63. Lucas A: Programming by early nutrition in man. In The Childhood Environment and Adult Disease: CIBA Symposium 156. Edited by Barker DJP. Chichester: John Wiley; 1991:38-55.
64. Hales CN, Barker DJ: Type 2 (non-insulin dependent) diabetes mellitus: the thrifty pheenotype hypothesis. Diabetologia 1992, 35:444-446.
65. Barker DJP, Hales CN, Fall CHD, Osmond C, Phipps K, Clark PMS: Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidemia (syndrome X): relation to reduced fetal growth. Diabetologia 1993, 36:62-67.
66. Bao W, Srinivasan SR, Wattigney WA, Berenson GS: Persistence of multiple cardiovascular risk clustering related to syndrome X from childhood to going adulthood: the Bogalusa heart study. Arch Intern Med 1994, 154:1842-1847.